Violation Tracker Parent Company Summary

Parent Company Name: 
Bausch Health
Ownership Structure: 
publicly traded (ticker symbol BHC)
Headquartered in: 
Canada (reincorporated for tax reasons)
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Penalty total since 2000: 
$355,305,378
Number of records: 
20
Top 5 Offense Groups (Groups Defined)Penalty TotalNumber of Records
financial offenses$201,005,5005
competition-related offenses$101,747,8765
government-contracting-related offenses$33,700,0002
healthcare-related offenses$9,800,0003
employment-related offenses$7,170,0023
Top 5 Primary Offense TypesPenalty TotalNumber of Records
investor protection violation$145,000,0001
kickbacks and bribery$78,647,8763
accounting fraud or deficiencies$56,000,0003
False Claims Act and related$33,700,0002
price-fixing or anti-competitive practices$17,500,0001
Notes: 

Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.

Associated Names: 

Bausch & Lomb; BAUSCH AND LOMB; Bausch Health; BIOVAIL; BIOVAIL AMERICAS; BIOVAIL PHARMACEUTICALS; ICN PHARMACEUTICALS; ISTA Pharmaceuticals, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals Inc.; Valeant Pharmaceuticals International, Inc.; Valeant Pharmaceuticals, Inc.

Links: 

Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.


Individual Penalty Records:

Click on the company or penalty amount for more information on each case.
Download results as CSV or XML
Company Primary Offense Type Year Agency Penalty Amountsort icon
Valeant Pharmaceuticals International, Inc. investor protection violation 2017 MULTI-AG $145,000,000
Salix Pharmaceuticals Inc. kickbacks and bribery 2016 USAO $54,000,000
Bausch Health accounting fraud or deficiencies 2020 SEC $45,000,000
ISTA Pharmaceuticals, Inc. False Claims Act and related 2013 DOJ_CIVIL $33,500,000
Biovail Pharmaceuticals Inc. kickbacks and bribery 2009 USAO $24,647,876
Bausch & Lomb price-fixing or anti-competitive practices 2001 MULTI-AG $17,500,000
Biovail Corporation accounting fraud or deficiencies 2008 SEC $10,000,000
Medicis Pharmaceutical Corporation off-label or unapproved promotion of medical products 2007 DOJ_CIVIL $9,800,000
Salix Pharmaceuticals Inc. kickbacks and bribery 2016 MULTI-AG (*) $7,470,000
Medicis Pharmaceutical employment discrimination 2016 private lawsuit-federal $7,150,000
ICN Pharmaceuticals, Inc. fraud 2001 USAO $5,600,000
Medicis Pharmaceutical Corporation off-label or unapproved promotion of medical products 2007 MULTI-AG (*) $4,000,000
Valeant Pharmaceuticals, Inc. insurance violation 2018 CA-INS $1,875,000
ICN Pharmaceuticals, Inc. accounting fraud or deficiencies 2002 SEC $1,000,000
ISTA Pharmaceuticals, Inc. off-label or unapproved promotion of medical products 2013 MULTI-AG (*) $390,253
Biovail False Claims Act and related 2013 LA-AG $200,000
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. benefit plan administrator violation 2016 EBSA $10,001
BIOVAIL AMERICAS CORP. benefit plan administrator violation 2012 EBSA $10,001
BAUSCH AND LOMB PHARMACEUTICALS, INC. workplace safety or health violation 2000 OSHA $7,000
ICN Pharmaceuticals, Inc economic sanction violation 2004 OFAC $5,500
Download results as CSV or XML